Phentolamine hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C17H19N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86DRW83R1H, chemically known as 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)phenol hydrochloride but more generally known as phentolamine hydrochloride, which bears US NIH Compound Identifier 66147. European Medicines Agency schedules Phentolamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22729. Most nations, for tariff and trade purposes, schedule phentolamine hydrochloride under HS 29332910 and SITC 51573. As of Q4 2014, PHENTOLAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Phentolamine hydrochloride bears US NLM identifiers UMLS ID C2698793 and NCI Concept Code C80007. SMILES: CC1CCC(CC1)N(CC2=NCCN2)C3CCCC(C3)O.CL.